Australia markets close in 6 hours 7 minutes

Stoke Therapeutics, Inc. (STOK)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
11.60-0.34 (-2.85%)
At close: 04:00PM EDT
11.89 +0.29 (+2.50%)
After hours: 07:10PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 622.31M
Enterprise value 422.98M
Trailing P/E 21.65
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)68.38
Price/book (mrq)4.43
Enterprise value/revenue 53.92
Enterprise value/EBITDA -3.57

Trading information

Stock price history

Beta (5Y monthly) 0.76
52-week change 32.49%
S&P500 52-week change 325.38%
52-week high 316.40
52-week low 33.35
50-day moving average 310.12
200-day moving average 36.18

Share statistics

Avg vol (3-month) 31.32M
Avg vol (10-day) 3813.89k
Shares outstanding 552.12M
Implied shares outstanding 652.78M
Float 839.98M
% held by insiders 14.65%
% held by institutions 181.11%
Shares short (15 Apr 2024) 45.53M
Short ratio (15 Apr 2024) 41.94
Short % of float (15 Apr 2024) 415.98%
Short % of shares outstanding (15 Apr 2024) 410.61%
Shares short (prior month 15 Mar 2024) 43.55M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-672.96%

Management effectiveness

Return on assets (ttm)-30.41%
Return on equity (ttm)-61.29%

Income statement

Revenue (ttm)7.84M
Revenue per share (ttm)0.17
Quarterly revenue growth (yoy)-18.20%
Gross profit (ttm)N/A
EBITDA -116.02M
Net income avi to common (ttm)-108.53M
Diluted EPS (ttm)-2.42
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)178.58M
Total cash per share (mrq)3.43
Total debt (mrq)6.34M
Total debt/equity (mrq)4.52%
Current ratio (mrq)5.43
Book value per share (mrq)3.02

Cash flow statement

Operating cash flow (ttm)-84.28M
Levered free cash flow (ttm)-41.85M